Zilia Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
27
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$3.5M
- Investors
-
15
Zilia General Information
Description
Developer of a non-invasive medtech platform designed to measure biomarkers in the eye. The company's platform offers advanced imaging, spectrometry, optical analysis and artificial intelligence-based interpretation tools to leverage the eye's optical properties and its connection to the vascular system and brain, enabling eye care professionals and healthcare practitioners to assess physiological changes, identify potential disease indicators, and support earlier intervention.
Contact Information
Website
www.ziliahealth.comCorporate Office
- 125 Charest Boulevard East
- Suite 400
- Quebec, Quebec G1K 3G5
- Canada
Corporate Office
- 125 Charest Boulevard East
- Suite 400
- Quebec, Quebec G1K 3G5
- Canada
Zilia Timeline
Zilia Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 16. Later Stage VC | 07-May-2025 | $3.5M | Completed | Product Development | ||
| 15. Grant | 31-Dec-2024 | Completed | Product Development | |||
| 14. Later Stage VC | 26-Jul-2024 | Completed | Product Development | |||
| 13. Accelerator/Incubator | 11-Sep-2023 | Completed | Product Development | |||
| 12. Accelerator/Incubator | 23-Jun-2023 | Completed | Product Development | |||
| 11. Grant | 31-Dec-2022 | Completed | Product Development | |||
| 10. Accelerator/Incubator | 01-Jan-2022 | Completed | Product Development | |||
| 9. Grant | 31-Dec-2021 | Completed | Product Development | |||
| 8. Seed Round | 11-Aug-2021 | $5.2M | $5.55M | Completed | Product Development | |
| 7. Grant | 31-Dec-2020 | $1.08M | $350K | Completed | Product Development |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Zilia Patents
Zilia Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026178665-A1 | Methods and systems for characterizing the tissues of the fundus of the eye of a subject | Pending | 28-Feb-2025 | ||
| CA-3231496-A1 | Multimodal device for spectral and oct acquisitions | Active | 15-Nov-2022 | ||
| EP-4583757-A1 | Multimodal device for spectral and oct acquisitions | Pending | 15-Nov-2022 | ||
| EP-4583757-A4 | Multimodal device for spectral and oct acquisitions | Pending | 15-Nov-2022 | ||
| US-20260123835-A1 | Multimodal device for spectral and oct acquisitions | Pending | 15-Nov-2022 | A61B3/1225 |
Zilia Signals
Zilia Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Linearis | Venture Capital | Minority | ||
| Esplanade Québec | Accelerator/Incubator | |||
| Medical Alley Association | Accelerator/Incubator | |||
| Government of Quebec | Government | |||
| Keihanna Global Acceleration Program | Accelerator/Incubator |
Zilia FAQs
-
When was Zilia founded?
Zilia was founded in 2017.
-
Where is Zilia headquartered?
Zilia is headquartered in Quebec, Canada.
-
What is the size of Zilia?
Zilia has 27 total employees.
-
What industry is Zilia in?
Zilia’s primary industry is Diagnostic Equipment.
-
Is Zilia a private or public company?
Zilia is a Private company.
-
What is Zilia’s current revenue?
The current revenue for Zilia is .
-
How much funding has Zilia raised over time?
Zilia has raised $14.2M.
-
Who are Zilia’s investors?
Linearis, Esplanade Québec, Medical Alley Association, Government of Quebec, and Keihanna Global Acceleration Program are 5 of 15 investors who have invested in Zilia.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process